Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Scientific Reports|July 19, 2022
Determination of starting dose of the T cell-redirecting bispecific antibody ERY974 targeting glypican-3 in first-in-human clinical trialShun-Ichiro Komatsu, Yoko Kayukawa, Yoko Miyazaki, et al.Journal of the Neurological Sciences|August 11, 2024
Involvement of the nigrostriatal system in Gerstman-Sträussler-Scheinker disease with the PRNP-P102L mutationNatsuki Ono, Kohei Suzuyama, Hiromu Minagawa, et al.Journal of the Neurological Sciences|June 12, 2025
Characteristics of meningitis/encephalitis in adult patients with varicella-zoster virus infection: Experience from tertiary centers in Saga prefecture, JapanKeisuke Tsumura, Yukako Inoue, Yuta Goto, et al.Hypertension Research : Official Journal of the Japanese Society of Hypertension|September 19, 2024
Cerebral small vessel disease markers and long-term prognosis in spontaneous intracerebral hemorrhage: the HAGAKURE-ICH studyShuhei Ikeda, Yusuke Yakushiji, Jun Tanaka, et al.Frontiers in Aging Neuroscience|March 20, 2023
Hypertension, cerebral Amyloid, aGe Associated Known neuroimaging markers of cerebral small vessel disease Undertaken with stroke REgistry (HAGAKURE) prospective cohort study: Baseline characteristics and association of cerebral small vessel disease with prognosis in an ischemic stroke cohortShuhei Ikeda, Yusuke Yakushiji, Jun Tanaka, et al.Science Translational Medicine|October 6, 2017
An anti-glypican 3/CD3 bispecific T cell-redirecting antibody for treatment of solid tumorsTakahiro Ishiguro, Yuji Sano, Shun-Ichiro Komatsu, et al.Cancer Discovery|August 28, 2020
Antibody to CD137 Activated by Extracellular Adenosine Triphosphate Is Tumor Selective and Broadly Effective <i>In Vivo</i> without Systemic Immune ActivationMika Kamata-Sakurai, Yoshinori Narita, Yuji Hori, et al.Pageof 2